Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chie Emoto

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Clinical Pharmacology|August 11, 2015
The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically-based pharmacokinetic modelChie Emoto, Tsuyoshi Fukuda, Raja Venkatasubramanian, et al.
Journal of Clinical Pharmacology|July 26, 2023
Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal ExcretionTrevor N Johnson, Khaled Abduljalil, Xian Pan, et al.
Current Drug Metabolism|October 27, 2010
Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contributionChie Emoto, Norie Murayama, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 27, 2016
Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to ChildrenDavid Hahn, Chie Emoto, Alexander A Vinks, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazoleChie Emoto, Shigeo Murase, Yasufusa Sawada, et al.
European Journal of Clinical Pharmacology|February 2, 2021
Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its dispositionChie Emoto, Trevor N Johnson, Takaaki Yamada, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 17, 2017
Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damagesMasateru Miyake, Takanori Minami, Hiroyuki Yamazaki, et al.
European Journal of Medicinal Chemistry|April 5, 2016
Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivativesShigeo Hayashi, Katsuyo Ohashi, Sachiko Mihara, et al.
Biopharmaceutics & Drug Disposition|November 7, 2019
Adult and infant pharmacokinetic profiling of dihydrocodeine using physiologically based pharmacokinetic modelingMiki Ota, Makiko Shimizu, Yusuke Kamiya, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2018
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK ObservationsChie Emoto, Trevor N Johnson, Brooks T McPhail, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Clinical Pharmacology|August 11, 2015
The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically-based pharmacokinetic modelChie Emoto, Tsuyoshi Fukuda, Raja Venkatasubramanian, et al.
Journal of Clinical Pharmacology|July 26, 2023
Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal ExcretionTrevor N Johnson, Khaled Abduljalil, Xian Pan, et al.
Current Drug Metabolism|October 27, 2010
Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contributionChie Emoto, Norie Murayama, Amin Rostami-Hodjegan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 27, 2016
Developmental Changes in Hepatic Organic Cation Transporter OCT1 Protein Expression from Neonates to ChildrenDavid Hahn, Chie Emoto, Alexander A Vinks, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazoleChie Emoto, Shigeo Murase, Yasufusa Sawada, et al.
European Journal of Clinical Pharmacology|February 2, 2021
Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its dispositionChie Emoto, Trevor N Johnson, Takaaki Yamada, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 17, 2017
Arachidonic acid with taurine enhances pulmonary absorption of macromolecules without any serious histopathological damagesMasateru Miyake, Takanori Minami, Hiroyuki Yamazaki, et al.
European Journal of Medicinal Chemistry|April 5, 2016
Discovery of small-molecule nonpeptide antagonists of nociceptin/orphanin FQ receptor: The studies of design, synthesis, and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero)cycloalkanobenzene] derivativesShigeo Hayashi, Katsuyo Ohashi, Sachiko Mihara, et al.
Biopharmaceutics & Drug Disposition|November 7, 2019
Adult and infant pharmacokinetic profiling of dihydrocodeine using physiologically based pharmacokinetic modelingMiki Ota, Makiko Shimizu, Yusuke Kamiya, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 16, 2018
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case-Based Clinical PK ObservationsChie Emoto, Trevor N Johnson, Brooks T McPhail, et al.
Pageof 5